Carregant...
Euglycemic Diabetic Ketoacidosis in a Lung Cancer Patient Using Empagliflozin
Diabetic ketoacidosis is a leading cause of morbidity and mortality in diabetic patients, and its diagnosis should be timely and accurate. SGLT2 inhibitors are a new class of antidiabetic medications that increase the renal excretion of glucose. It is thought that increased urinary excretion of gluc...
Guardat en:
| Publicat a: | Case Rep Crit Care |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Hindawi
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7350083/ https://ncbi.nlm.nih.gov/pubmed/32695525 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/7437892 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|